TickerFactsScreenerDevelopers

ArriVent BioPharma, Inc. (AVBP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$55.84M2024: -$70.21M2025: -$160.59M-$160.59M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$160.59M-128.7%
2024-$70.21M-25.7%
2023-$55.84M—